Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 3
Submit an article Journal homepage
161
Views
5
CrossRef citations to date
0
Altmetric
Letters to the Editor

Treatment modalities and overall survival outcomes for sinonasal extranodal natural killer/T-cell lymphoma

Brandon M. Lehricha Medical Scientist Training Program, University of Pittsburgh and Carnegie Mellon University, Pittsburgh, PA, USA;b Department of Otolaryngology–Head and Neck Surgery, University of California, Irvine, CA, USAORCID Iconhttps://orcid.org/0000-0003-1003-5605View further author information
ORCID Icon,
Khodayar Goshtasbib Department of Otolaryngology–Head and Neck Surgery, University of California, Irvine, CA, USAORCID Iconhttps://orcid.org/0000-0002-0045-2547View further author information
ORCID Icon,
Arash Abirib Department of Otolaryngology–Head and Neck Surgery, University of California, Irvine, CA, USAORCID Iconhttps://orcid.org/0000-0003-2656-1060View further author information
ORCID Icon,
Tyler M. Yasakab Department of Otolaryngology–Head and Neck Surgery, University of California, Irvine, CA, USAORCID Iconhttps://orcid.org/0000-0002-8482-0369View further author information
ORCID Icon,
Peter Papagiannopoulosc Department of Otorhinolaryngology–Head and Neck Surgery, Rush University Medical Center, Chicago, IL, USAView further author information
,
Bobby A. Tajudeenc Department of Otorhinolaryngology–Head and Neck Surgery, Rush University Medical Center, Chicago, IL, USAView further author information
,
Elizabeth A. Bremd Department of Hematology and Oncology, University of California, Irvine, CA, USAView further author information
&
Edward C. Kuanb Department of Otolaryngology–Head and Neck Surgery, University of California, Irvine, CA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-3475-0718View further author information
ORCID Icon show all
Pages 727-730 | Received 22 Feb 2020, Accepted 03 Oct 2020, Published online: 15 Oct 2020

References

  • Campo E, Swerdlow SH, Harris NL, Pileri S, et al. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. 2011;117(19):5019–5032.
  • Harabuchi Y, Takahara M, Kishibe K, et al. Extranodal natural killer/T-cell lymphoma, nasal type: basic science and clinical progress. Front Pediatr. 2019;7:141.
  • Li S, Feng X, Fau-Li T, et al. Extranodal NK/T-cell lymphoma, nasal type: a report of 73 cases at MD Anderson Cancer Center. Am J Surg Pathol. 2013;37:14–23.
  • Varelas AN, Ganti A, Eggerstedt M, et al. Prognostic indicators of survival in sinonasal extranodal natural killer/T-cell lymphoma. Laryngoscope. 2019;0:1–6.
  • Vazquez A, Khan MN, Blake DM, et al. Extranodal natural killer/T-Cell lymphoma: a population-based comparison of sinonasal and extranasal disease. Laryngoscope. 2014;124(4):888–895.
  • Vargo JA, Patel A, Glaser SM, et al. The impact of the omission or inadequate dosing of radiotherapy in extranodal natural killer T-cell lymphoma, nasal type, in the United States. Cancer. 2017;123(16):3176–3185.
  • Takenaka K, Shinagawa K, Maeda Y, et al. High-dose chemotherapy with hematopoietic stem cell transplantation is effective for nasal and nasal-type CD56+ natural killer cell lymphomas. Leuk Lymphoma. 2001;42(6):1297–1303.
  • Su C, Nguyen KA, Bai HX, et al. Comparison of chemoradiotherapy with radiotherapy alone for early-stage extranodal natural killer/T-cell lymphoma, nasal type in elderly patients. Leuk Lymphoma. 2018;59(6):1406–1412.
  • Hsueh CY, Yang CF, Gau JP, et al. Nasopharyngeal lymphoma: a 22-year review of 35 cases. J Clin Med. 2019;8:1604.
  • Kim SJ, Yoon SE, Kim WS. Treatment of localized extranodal NK/T cell lymphoma, nasal type: a systematic review. J Hematol Oncol. 2018;11(1):140.
  • Yamaguchi M, Suzuki R, Oguchi M. Advances in the treatment of extranodal NK/T-cell lymphoma, nasal type. Blood. 2018;131(23):2528–2540.
  • Yang Y, Zhu Y, Cao JZ, et al. Risk-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma: analysis from a multicenter study. Blood. 2015;126(12):1424–1432. quiz 1517.
  • Kanate AS, DiGilio A, Ahn KW, et al. Allogeneic haematopoietic cell transplantation for extranodal natural killer/T-cell lymphoma, nasal type: a CIBMTR analysis. Br J Haematol. 2018;182(6):916–920.
  • Yhim HY, Kim JS, Mun YC, et al. Clinical outcomes and prognostic factors of up-front autologous stem cell transplantation in patients with extranodal natural killer/T cell lymphoma. Biol Blood Marrow Transplant. 2015;21(9):1597–1604.
  • Fox CP, Boumendil A, Schmitz N, et al. High-dose therapy and autologous stem cell transplantation for extra-nodal NK/T lymphoma in patients from the Western hemisphere: a study from the European Society for Blood and Marrow Transplantation. Leuk Lymphoma. 2015;56(12):3295–3300.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.